BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15822051)

  • 1. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes.
    Placha G; Canani LH; Warram JH; Krolewski AS
    Adv Chronic Kidney Dis; 2005 Apr; 12(2):155-69. PubMed ID: 15822051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.
    Rogus JJ; Poznik GD; Pezzolesi MG; Smiles AM; Dunn J; Walker W; Wanic K; Moczulski D; Canani L; Araki S; Makita Y; Warram JH; Krolewski AS
    Diabetes; 2008 Sep; 57(9):2519-26. PubMed ID: 18559660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic factors in diabetic nephropathy.
    Freedman BI; Bostrom M; Daeihagh P; Bowden DW
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1306-16. PubMed ID: 17942768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
    Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome scan for diabetic nephropathy in African Americans.
    Bowden DW; Colicigno CJ; Langefeld CD; Sale MM; Williams A; Anderson PJ; Rich SS; Freedman BI
    Kidney Int; 2004 Oct; 66(4):1517-26. PubMed ID: 15458446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes.
    Pezzolesi MG; Poznik GD; Mychaleckyj JC; Paterson AD; Barati MT; Klein JB; Ng DP; Placha G; Canani LH; Bochenski J; Waggott D; Merchant ML; Krolewski B; Mirea L; Wanic K; Katavetin P; Kure M; Wolkow P; Dunn JS; Smiles A; Walker WH; Boright AP; Bull SB; ; Doria A; Rogus JJ; Rich SS; Warram JH; Krolewski AS
    Diabetes; 2009 Jun; 58(6):1403-10. PubMed ID: 19252134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians.
    Pavkov ME; Knowler WC; Bennett PH; Looker HC; Krakoff J; Nelson RG
    Kidney Int; 2006 Nov; 70(10):1840-6. PubMed ID: 17003816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genome-wide association study for diabetic nephropathy genes in African Americans.
    McDonough CW; Palmer ND; Hicks PJ; Roh BH; An SS; Cooke JN; Hester JM; Wing MR; Bostrom MA; Rudock ME; Lewis JP; Talbert ME; Blevins RA; Lu L; Ng MC; Sale MM; Divers J; Langefeld CD; Freedman BI; Bowden DW
    Kidney Int; 2011 Mar; 79(5):563-72. PubMed ID: 21150874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Chromosomal Regions Linked to Diabetic Nephropathy: A Meta-Analysis of Genome-Wide Linkage Scans.
    Tziastoudi M; Stefanidis I; Stravodimos K; Zintzaras E
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):105-117. PubMed ID: 30694714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.
    Maeda S; Kobayashi MA; Araki S; Babazono T; Freedman BI; Bostrom MA; Cooke JN; Toyoda M; Umezono T; Tarnow L; Hansen T; Gaede P; Jorsal A; Ng DP; Ikeda M; Yanagimoto T; Tsunoda T; Unoki H; Kawai K; Imanishi M; Suzuki D; Shin HD; Park KS; Kashiwagi A; Iwamoto Y; Kaku K; Kawamori R; Parving HH; Bowden DW; Pedersen O; Nakamura Y
    PLoS Genet; 2010 Feb; 6(2):e1000842. PubMed ID: 20168990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linkage analysis of candidate loci for end-stage renal disease due to diabetic nephropathy.
    Iyengar SK; Fox KA; Schachere M; Manzoor F; Slaughter ME; Covic AM; Orloff SM; Hayden PS; Olson JM; Schelling JR; Sedor JR
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S195-201. PubMed ID: 12819328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes.
    Krolewski AS; Poznik GD; Placha G; Canani L; Dunn J; Walker W; Smiles A; Krolewski B; Fogarty DG; Moczulski D; Araki S; Makita Y; Ng DP; Rogus J; Duggirala R; Rich SS; Warram JH
    Kidney Int; 2006 Jan; 69(1):129-36. PubMed ID: 16374433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study.
    Freedman BI; Bowden DW; Rich SS; Xu J; Wagenknecht LE; Ziegler J; Hicks PJ; Langefeld CD
    Diabet Med; 2008 Mar; 25(3):268-76. PubMed ID: 18307454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylenetetrahydrofolate reductase gene polymorphism and susceptibility to diabetic nephropathy in type 1 diabetes.
    Makita Y; Moczulski DK; Bochenski J; Smiles AM; Warram JH; Krolewski AS
    Am J Kidney Dis; 2003 Jun; 41(6):1189-94. PubMed ID: 12776270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mining the genome for susceptibility to diabetic nephropathy: the role of large-scale studies and consortia.
    Iyengar SK; Freedman BI; Sedor JR
    Semin Nephrol; 2007 Mar; 27(2):208-22. PubMed ID: 17418689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmasking of proteinuria in the course of genetic dissection of nonproteinuric diabetic nephropathy.
    Yagil Y; Roif D; Sapojnikov M; Ben-Dor D; Tobar A; Rosenmann E; Yagil C
    Physiol Genomics; 2014 Jan; 46(1):29-38. PubMed ID: 24192394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY; Chen LS; Zhang LC; Zhou TB
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel genetic susceptibility loci for diabetic end-stage renal disease identified through robust naive Bayes classification.
    Sambo F; Malovini A; Sandholm N; Stavarachi M; Forsblom C; Mäkinen VP; Harjutsalo V; Lithovius R; Gordin D; Parkkonen M; Saraheimo M; Thorn LM; Tolonen N; Wadén J; He B; Osterholm AM; Tuomilehto J; Lajer M; Salem RM; McKnight AJ; ; Tarnow L; Panduru NM; Barbarini N; Di Camillo B; Toffolo GM; Tryggvason K; Bellazzi R; Cobelli C; ; Groop PH
    Diabetologia; 2014 Aug; 57(8):1611-22. PubMed ID: 24871321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.